Friday, February 10, 2012
"The source for European pharmaceutical biotechnology news..."
Sponsors
Platinum Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Areas
Roundtables
-
Efficiency of drug development methodologies
With the discipline of drug development under the industry microscope, NGP talks to two leading experts to find out what techniques are being employed to push the...Read more
Vendor Perspectives
-
Leveraging research informatics to accel...
The main drivers of research innovation in the Life Science industry are patent expiries, pricing pressures, evolving therapeutic needs and the advent of biologics for drug...Read more -
The NHS QIPP challenge: A collaborative ...
The concept of joint working between the National Health Service (NHS) and the biopharmaceutical industry on a broad agenda for the benefit of patients is a promising one....Read more -
Technology assists life sciences compani...
Thanks to new technologies, progressive companies are seeing manufacturing as a strategic asset and are investing in automation systems and MES, as well as improving...Read more -
Integrated solutions for the perfect lab...
The key to optimization potential in laboratory and quality management lies in their technical and organizational integration into the production process. With this in...Read more -
Veolia Environnement
In a globalised and connected world with increasing environmental regulations, to keep competitive in your industry, you need to perform on every single task your...Read more -
Integrating QbD into your PDP
Cindi Wilson of Total Flow Limited highlights the benefits and challenges of implementing and sustaining Quality by Design (QbD). Her solution is a visual flow embedded...Read more
Industry Analysts
-
Step up to the MIQE
When it comes to real-time PCR in drug discovery, Richard Kurtz believes that MIQE guidelines will help create a clear path to better results.Read more -
Real-time data for manufacturing
Craig Dobbs of Waters describes definitive technologies for PAT and QbD initiatives.Read more -
Enabling drug development by efficient dat...
R Arun Kumar, Associate Vice President and Head of Global Life Sciences practice at Infosys, discusses the influence of data management systems on drug development.Read more -
Combination tactics for orphan drug manufa...
Marc Botteman explains how orphan drug manufacturers can combine pricing and market access strategies with health economics to optimise pricing and market access.Read more -
Pharmaceutical supply chain progression
NGP finds out what is Nycomed doing to progress its manufacturing and supply chain operations.Read more -
Health spoken here
‘Health Spoken Here’. Three simple words that encapsulate the world of change that health-focused brands now compete in globally. They also embody the guiding philosophy...Read more
Executive Interviews
Enabling greater clinical trial efficiency
Paula Mchale delves into the world of clinical trials and offers her expertise on how technology could enable better efficiency.
Read more
Barriers to successful biopharmaceutical commer...
Mike Ackermann, Vice President of Global Commercial Strategy and Alliance at Quintiles, illuminates the significant barriers to successful biopharmaceutical commercialisation.
Read more
Pharma manufacturing supply chain
Amgen’s Madhavan Balachandran on why persistence is key to implementing an Operational Excellence campaign
Read more
NGP Europe Summit: Drug Discovery
5th - 7th April 2011
The Next Generation Drug Discovery Summit Europe is designed to bridge the growing technological gap between drug discovery and drug development.
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.